Sell Side Analyst Coverage
| Firm | Current Rating |
|---|---|
| Bank of America Merrill Lynch | Buy |
| Chardan Capital Markets | Buy |
| Citi Research | Neutral/High Risk |
| Cowen and Company | Outperform |
| Evercore ISI | Buy |
| Guggenheim Securities LLC | Buy |
| Jefferies LLC | Buy |
| Leerink Swann & Company | Outperform |
| J.P. Morgan Securities LLC | Overweight |
| RBC Capital Markets, LLC | Outperform |
| H.C. Wainwright & Co. | Buy |
Updated as of Dec 5, 2016.
Please note that any opinions, estimates or forecasts regarding The Medicines Company’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of The Medicines Company or its management. The Medicines Company does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
Please note that any opinions, estimates or forecasts regarding The Medicines Company’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of The Medicines Company or its management. The Medicines Company does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.